Mini-symposium: Genome Editing using CRISPR/Cas9

CRISPR based genome editing technologies are revolutionizing academia, life science and are expected to found the basis for next generation gene therapies. This years mini-symposium will focus on the latest developments in the use of CRISPR/Cas9, repurposed Cas9 based technologies and their use in whole animal and translational research.

Patrick Hsu, The Salk Institute, USA
Jacob Corn, Berkeley, USA/ETH in Zurich, Ch
Katherine Pawelczak , NERx Biosciences, Inc, USA
Marie Christine Birling, Phenomin ICS, Strasbourg, Fr
Vincenzo DiDonato, ZeClinics, Es
Thomas Tiilmark Eriksen, Lundbeck A/S, Dk
Massimo Squatrito, cnio, Es
Ed Ryder, Welcome Trust Sanger Institute, Cambridge, UK
Carol Elvira, ThermoFisher, USA
Gurpreet Balrey, Merckgroup, UK

The mini-symposium opens at 9am and ends at 5pm Registration (free) is required for participation and limited to 100 participants Registration is open from November 5th to 30th, through the following link: